Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study (Q46636533)
Jump to navigation
Jump to search
scientific article published on 5 August 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study |
scientific article published on 5 August 2005 |
Statements
1 reference
Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study (English)
1 reference
G Boner
1 reference
M E Cooper
1 reference
K McCarroll
1 reference
B M Brenner
1 reference
D de Zeeuw
1 reference
P R Kowey
1 reference
S Shahinfar
1 reference
T Dickson
1 reference
R S Crow
1 reference
H-H Parving
1 reference
RENAAL Investigators
1 reference
5 August 2005
1 reference
1 reference
48
1 reference
10
1 reference
1980-1987
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference